DepressionNCT05499182
Latino Teen Depression Treatment Study
An observational study of Depression, run by Duke University at 1 site in United States.
Trial summary
Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. Read more about this study
- Who is it for?
- Ages 13 years and olderHealthy volunteers can take part
- Conditions the study is for
- Depression
- How many people
- 35 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Oct 2022to 30 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Three samples will be recruited on a national scale: Latino male teens diagnosed with depression, their parents/guardians, and healthcare providers (behavioral health and primary care) who regularly care for Latino adolescents.
Who may be able to join
- Male gender
- Aged 13-17 years
- Diagnosed with Major Depressive Disorder or Persistent Depressive Disorder
- Referred to psychotherapy and/or prescribed antidepressant medications for depression
- Parent or legal guardian of teen
- Able to read and speak English or Spanish
- Self-identification as regularly providing clinical care to Latino adolescents with depression
- Be in a role in which they can provide or refer patients to depression treatment
Who cannot join
- Experiencing imminent thoughts of self-harm or suicide
- Experiencing acute psychological distress (e.g., uncontrolled crying)
- Unable to read/speak English or Spanish
- Unable to provide or refer to depression treatment
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Researchmatch.org
Nashville, Tennessee, 37232
Allison M Stafford, PhD
About this study
Official title: Identification of Implementation Strategies to Promote Depression Treatment Use Among Latino Adolescents
Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019). The purpose of this study is to identify a stakeholder-preferred implementation strategy that may improve psychotherapy attendance among Latino adolescents. Latino adolescent-parent dyads and healthcare providers will be recruited from healthcare settings and social media. Focus groups will be conducted with healthcare providers (n=5), and individual interviews will be conducted with Latino adolescents with a diagnosis of depression (n=15) and their parents (n=15).
- Conditions
- Depression
- Keywords
- Adolescent, Latino, Depression, Treatment
- Medical subject headings
- Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Teens | Teens are: 1) Male 2) Aged 13-17; 3) self-identified as Hispanic/Latino; 4) diagnosed with Major Depressive Disorder or Persistent Depressive Disorder/Dysthymia; and 5) referred to psychotherapy or prescribed medication for depression. Teens will be excluded if they are experiencing intense psychological distress or imminent thoughts of suicide. | |
| Parents | Parents will 1) Be parents or legal guardians of teens; and 2) Speak and read English or Spanish. | |
| Healthcare Providers | Healthcare providers will 1) Self-identify as regularly providing clinical care to Latino adolescents with depression; and 2) be in a role in which they can refer to or provide depression treatment. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Preferred implementation strategy to improve depression treatment use generated from qualitative interviews/focus groups
Implementation strategy preference options will include: 1) Near Peer Depression Support Groups; 2) Parent-Teen Depression Treatment Activation Training; and 3) Depression Care Navigation Services. We will determine which strategy is most preferred by asking stakeholders, "Which of these strategies would work best for you/your family/Latino teens?" We will add up the responses to determine the preferred strategy with the highest frequency.
Measured: Baseline
Secondary outcomes (1)
Number of barriers to depression treatment use generated from qualitative interviews/focus groups
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Aug 2022
- Study start13 Oct 2022
- Primary completion30 Dec 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DepressionStudies of the same condition, open and under way.
- More trials run by Duke UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 35 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Duke University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Allison M Stafford, PhD, Principal investigator, Duke University School of Nursing
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05499182
- Sponsor's protocol ID
- Pro00110026
- Status last verified
- Jan 2026
- First submitted
- 9 Aug 2022
- Last updated
- 15 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Due to the qualitative nature of this study, we will not be sharing participant data with other researchers.
Study at a glance
From the registry record, last updated by the sponsor on 15 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Identification of Implementation Strategies to Promote Depression Treatment Use Among Latino Adolescents
- ClinicalTrials.gov ID
- NCT05499182
- Acronym / sponsor ID
- Pro00110026
- Conditions
- Depression
- Keywords
- Adolescent, Latino, Depression, Treatment
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 35 participants (estimated)
- Lead sponsor
- Duke UniversityUniversity, hospital or other
- Study start
- 13 Oct 2022 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 12 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019). The purpose of this study is to identify a stakeholder-preferred implementation strategy that may improve psychotherapy attendance among Latino adolescents. Latino adolescent-parent dyads and healthcare providers will be recruited from healthcare settings and social media. Focus groups will be conducted with healthcare providers (n=5), and individual interviews will be conducted with Latino adolescents with a diagnosis of depression (n=15) and their parents (n=15).
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Teens | – | –Teens are: 1) Male 2) Aged 13-17; 3) self-identified as Hispanic/Latino; 4) diagnosed with Major Depressive Disorder or Persistent Depressive Disorder/Dysthymia; and 5) referred to psychotherapy or prescribed medication for depression. Teens will be excluded if they are experiencing intense psychological distress or imminent thoughts of suicide. |
| Parents | – | –Parents will 1) Be parents or legal guardians of teens; and 2) Speak and read English or Spanish. |
| Healthcare Providers | – | –Healthcare providers will 1) Self-identify as regularly providing clinical care to Latino adolescents with depression; and 2) be in a role in which they can refer to or provide depression treatment. |
Who may qualify
- Ages
- 13 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Three samples will be recruited on a national scale: Latino male teens diagnosed with depression, their parents/guardians, and healthcare providers (behavioral health and primary care) who regularly care for Latino adolescents.
Key inclusion criteria (8 listed)
- Male gender
- Aged 13-17 years
- Diagnosed with Major Depressive Disorder or Persistent Depressive Disorder
- Referred to psychotherapy and/or prescribed antidepressant medications for depression
- Parent or legal guardian of teen
Key exclusion criteria (4 listed)
- Experiencing imminent thoughts of self-harm or suicide
- Experiencing acute psychological distress (e.g., uncontrolled crying)
- Unable to read/speak English or Spanish
- Unable to provide or refer to depression treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Preferred implementation strategy to improve depression treatment use generated from qualitative interviews/focus groups
Time frame: Baseline
Implementation strategy preference options will include: 1) Near Peer Depression Support Groups; 2) Parent-Teen Depression Treatment Activation Training; and 3) Depression Care Navigation Services. We will determine which strategy is most preferred by asking stakeholders, "Which of these strategies would work best for you/your family/Latino teens?" We will add up the responses to determine the preferred strategy with the highest frequency.
1 secondary outcome
Number of barriers to depression treatment use generated from qualitative interviews/focus groups
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jan 2026.
- Individual participant dataSharing planned: No. Due to the qualitative nature of this study, we will not be sharing participant data with other researchers.
Related trials for Depression
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Allison M Stafford, PhD principal investigator
Duke University School of Nursing
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Depression, run by Duke University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 15 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Allison M Stafford, PhD ((317) 498-7333, allison.stafford@duke.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Preferred implementation strategy to improve depression treatment use generated from qualitative interviews/focus groups (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2026.